Glaxo Smith Kline to build pharma plant in India
(Picture: PROCESS)
Glaxo Smith Kline (GSK) has recently announced its plan to build a new factory. For this upcoming facility the company is expected to invest Rs. 864 crore. The company will partner with local design and construction companies to build a state-of-the-art manufacturing facility which is expected to benefit from leading edge technologies including continuous manufacturing and automated systems.
Mumbai/India - When complete, the new factory will make pharmaceutical products for the Indian market at a rate of up eight billion tablets and one billion capsules a year. The facility, expected to be operational by 2017, will also include a warehouse, site infrastructure and utilities to support the manufacturing and packing of the medicines.
